-
公开(公告)号:US20120289502A1
公开(公告)日:2012-11-15
申请号:US13558325
申请日:2012-07-25
申请人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
发明人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
IPC分类号: A61K31/4164 , A61P25/00 , A61K31/5377 , A61K31/4439 , A61K31/454
CPC分类号: C07D233/64 , C07D401/04 , C07D405/06 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I): [wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
摘要翻译: 包含由通式(I)表示的咪唑衍生物的CB2受体调节剂:[其中,R 1表示任选取代的低级烷基等; R2代表任选取代的环烷基等; R3表示任选取代的芳基等; 和n表示0〜3的整数]或其药学上可接受的盐作为活性成分,等。
-
公开(公告)号:US08236841B2
公开(公告)日:2012-08-07
申请号:US12310926
申请日:2007-09-13
申请人: Takashi Sawada , Naoto Osakada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Keishi Katayama
发明人: Takashi Sawada , Naoto Osakada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Keishi Katayama
IPC分类号: A01N43/52 , A01N43/54 , A01N43/90 , A61K31/415 , A61K31/517 , A61K31/519 , C07D235/00 , C07D487/00
CPC分类号: C07D471/04 , C07D487/04
摘要: A fused heterocycle derivative represented by the general formula (I): (wherein R1 represents optionally substituted lower alkyl, or the like; R2 represents an optionally substituted aliphatic heterocyclic group, or the like; R3 represents —C(═Z)NR5R6 (wherein R5 and R6 represent optionally substituted lower alkyl, or the like, and Z represents an oxygen atom or the like), or the like; n represents an integer of 1 to 3; and W represents C—R5 (wherein R5 represents a hydrogen atom or the like)) or a pharmaceutically acceptable salt thereof, and the like are provided.
摘要翻译: 由通式(I)表示的稠合杂环衍生物:其中R 1表示任选取代的低级烷基等; R 2表示任选取代的脂族杂环基等; R 3表示-C(= Z)NR 5 R 6(其中 R 5和R 6表示任选取代的低级烷基等,Z表示氧原子等)等; n表示1〜3的整数,W表示C-R5(式中,R5表示氢原子 等))或其药学上可接受的盐等。
-
公开(公告)号:US08273738B2
公开(公告)日:2012-09-25
申请号:US12440237
申请日:2007-09-05
申请人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
发明人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
IPC分类号: A61K31/535 , A61K31/4965
CPC分类号: C07D233/64 , C07D401/04 , C07D405/06 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I): [wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
摘要翻译: 包含由通式(I)表示的咪唑衍生物的CB2受体调节剂:[其中,R 1表示任选取代的低级烷基等; R2代表任选取代的环烷基等; R3表示任选取代的芳基等; 和n表示0〜3的整数]或其药学上可接受的盐作为活性成分,等。
-
公开(公告)号:US20100152178A1
公开(公告)日:2010-06-17
申请号:US12440237
申请日:2007-09-05
申请人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
发明人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
IPC分类号: A61K31/5377 , C07D233/64 , A61K31/4174 , C07D401/04 , A61K31/4439 , C07D401/10 , A61K31/454 , C07D413/10 , C07D471/04 , A61K31/519 , C07D401/14 , A61K31/497 , C07D413/14 , A61P29/00 , A61P25/06 , A61P25/00 , A61P37/08 , A61P37/00 , A61P19/02 , A61P1/00 , A61P25/28 , A61P11/06 , A61P11/00 , A61P17/00 , A61P9/10 , A61P3/04 , A61P19/10 , A61P27/06
CPC分类号: C07D233/64 , C07D401/04 , C07D405/06 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I): [wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
摘要翻译: 包含由通式(I)表示的咪唑衍生物的CB2受体调节剂:[其中,R 1表示任选取代的低级烷基等; R2代表任选取代的环烷基等; R3表示任选取代的芳基等; 和n表示0〜3的整数]或其药学上可接受的盐作为活性成分,等。
-
公开(公告)号:US20090239853A1
公开(公告)日:2009-09-24
申请号:US12310926
申请日:2007-09-13
申请人: Takashi Sawada , Naoto Osakada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Keishi Katayama
发明人: Takashi Sawada , Naoto Osakada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Keishi Katayama
IPC分类号: A61K31/541 , C07D471/04 , A61K31/437 , A61K31/519 , C07D487/04 , A61P25/00
CPC分类号: C07D471/04 , C07D487/04
摘要: A fused heterocycle derivative represented by the general formula (I): (wherein R1 represents optionally substituted lower alkyl, or the like; R2 represents an optionally substituted aliphatic heterocyclic group, or the like; R3 represents —C(=Z)NR5R6 (wherein R5 and R6 represent optionally substituted lower alkyl, or the like, and Z represents an oxygen atom or the like), or the like; n represents an integer of 1 to 3; and W represents C—R5 (wherein R5 represents a hydrogen atom or the like)) or a pharmaceutically acceptable salt thereof, and the like are provided.
摘要翻译: 由通式(I)表示的稠合杂环衍生物:(其中R 1表示任选取代的低级烷基等; R 2表示任选取代的脂族杂环基等; R 3表示-C(= Z)NR 5 R 6(其中 R 5和R 6表示任选取代的低级烷基等,Z表示氧原子等)等; n表示1〜3的整数,W表示C-R5(式中,R5表示氢原子 等))或其药学上可接受的盐等。
-
-
-
-